Allergy management support service

Completed

• Conditions: Allergy: rhinitis, asthma, atopic dermatitis and food allergy; Respiratory

• Registration Number: ISRCTN36780877
• Lead Sponsor: niversity Medical Center Groningen

Brief Summary

2018 results in: https://www.ncbi.nlm.nih.gov/pubmed/29872524

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2016-09-01
• Study Start: 2017-11-23
• Last Update Posted: 2 July 2018

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

1. General practitioners (GP)
2. Allergic patient or parent of allergic child with sIgE test

Exclusion Criteria

Does not meet inclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Feasibility of the AMSS is assessed using the percentage of AMSS recommendations sent to the GP within 10 working days of the slgE testing.

Secondary Outcome Measures

Name	Time	Method
There are no secondary outcome measures.